期刊文献+

疏肝补肾汤联合炔雌醇环丙孕酮片治疗多囊卵巢综合征疗效观察 被引量:6

Effect Observation on Shugan Bushen Tang Combined with Cyproterone Acetate Tablets for Polycystic Ovary Syndrome
在线阅读 下载PDF
导出
摘要 目的:观察疏肝补肾汤联合炔雌醇环丙孕酮片治疗多囊卵巢综合征(PCOS)的临床疗效。方法:将PCOS患者86例随机分为2组各43例,对照组采用炔雌醇环丙孕酮片治疗,观察组采用炔雌醇环丙孕酮片联合疏肝补肾汤治疗,2组均以21天为1疗程,共治疗3疗程。观察2组治疗前后卵巢体积、子宫内膜厚度,检测睾酮(T)、黄体生成素(LH)、卵泡刺激素(FSH)、单核细胞趋化蛋白-1 (MCP-1)、谷胱甘肽过氧化物酶(GSH-Px)、晚期氧化蛋白产物(AOPP)、血管紧张素Ⅱ(AT-Ⅱ)、脂联素等水平变化;记录患者治疗后排卵、妊娠情况。结果:治疗后,观察组患者子宫内膜厚度厚于对照组,卵巢体积小于对照组,差异均有统计学意义(P <0.05)。治疗后,观察组患者T、LH、FSH水平低于对照组,差异均有统计学意义(P <0.05)。治疗后,观察组患者GSH-Px、脂联素水平高于对照组,MCP-1、AOPP、AT-Ⅱ水平低于对照组,差异均有统计学意义(P <0.05)。治疗后观察组患者排卵率、妊娠率均高于对照组,但组间比较,差异均无统计学意义(P> 0.05)。结论:疏肝补肾汤联合炔雌醇环丙孕酮片治疗PCOS可缩小卵巢体积,降低性激素、MCP-1、AT-Ⅱ水平,减轻氧化应激反应水平,从而促进排卵。 Objective: To observe the clinical effect of Shugan Bushen tang combined with cyproterone acetate tablets for polycystic ovary syndrome (PCOS). Methods:Divided 86 cases of patients with PCOS into two groups randomly,43 cases in each group. The control group was treated with cyproterone acetate tablets,while the observation group was treated with cyproterone acetate tablets combined with Shugan Bushen tang. The two groups received treatment for three courses,21 days being a course. Observed the volume of ovarian and endometrial thickness, detected the changes in levels of testosterone (T), luteinizing hormone (LH), follicle stimulating hormone(FSH),monocyte chemoattractant protein-1(MCP-1),glutathione peroxidase(GSH-Px),advanced oxidation protein products(AOPP),angiotensin Ⅱ(AT-Ⅱ) and adiponectin before and after treatment in the two groups,and recorded the ovulation and pregnancy of patients after treatment. Results:After treatment,endometrial thickness in the observation group was thicker than that in the control group,and the volume of ovarian was smaller than that in the control group,differences being significant(P<0.05). After treatment,levels of T,LH and FSH in the observation group were lower than those in the control group,differences being significant (P<0.05). After treatment,levels of GSH-Px and adiponectin in the observation group were higher than those in the control group, while levels of MCP-1,AOPP and AT-Ⅱ in the observation group were lower than those in the control group, differences being significant(P<0.05). After treatment,the ovulation rate and the pregnancy rate in the observation group were higher than those in the control group,but no significant difference was found in the comparisons of the ovulation rate and the pregnancy rate between the two groups (P>0.05). Conclusion:The therapy of Shugan Bushen tang combined with cyproterone acetate tablets for PCOS can reduce the volume of ovarian,decrease the levels of sex hormone,MCP-1 and AT-Ⅱ and relieve the oxidative stress reaction,so as to promote the ovulation.
作者 丁芳 DING Fang
出处 《新中医》 CAS 2018年第12期146-149,共4页 New Chinese Medicine
关键词 多囊卵巢综合征 疏肝补肾汤 炔雌醇环丙孕酮片 单核细胞趋化蛋白-1(MCP-1) 血管紧张素Ⅱ(AT-Ⅱ) Polycystic ovary syndrome Shugan Bushen tang Cyproterone acetate tablets Monocyte chemoattractant protein-1(MCP-1) Angiotensin Ⅱ(AT-Ⅱ)
作者简介 丁芳(1986-),女,主治中医师,研究方向:中医妇科学。
  • 相关文献

参考文献11

二级参考文献189

  • 1匡洪影,王秀霞.王秀霞教授治疗多囊卵巢综合征合并垂体微腺瘤1例[J].中医药学报,2011,39(4):83-84. 被引量:5
  • 2陈子江,哈灵侠.多囊卵巢综合征治疗进展[J].中华糖尿病杂志,2009,1(6). 被引量:1
  • 3蒋淑君,许兰芝.淫羊藿总黄酮的药理作用研究进展[J].中医药学报,2004,32(4):60-62. 被引量:45
  • 4蒋健.论辨证论治的缺陷及与辨病论治相结合的必要性[J].中西医结合学报,2005,3(2):85-87. 被引量:31
  • 5中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,1993:6-10
  • 6谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 7Jeffrey C, Mickey S. Polycystic ovary syndrome: early detection in the adolescent[J]. Clin Obstet Gyneco1,2007,50( 1 ) :178 - 187.
  • 8Kim EJ, Jung SN, Son KH, et al. Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP -activated protein kinase [ J ]. Mol Pharmaco1,2007,72 ( 1 ) :62 -72.
  • 9Sivayoganathan D, Maruthini D, Glanville JM, et al. Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties re- veals significant differences and undiagnosed morbidity [J]. Hum Fertil (Camb), 2011,14(2) : 261-265.
  • 10Taghavi SA, Bazarganipour F, Montazeri A, et al. Health- related quality of life in polycystic ovary syndrome pa- tients : a systematic review [J]. Iran J Reprod Med, 2015, 13(1) :473-482.

共引文献433

同被引文献86

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部